Open-Label Rollover Study of Levosimendan in PH-HFpEF Patients

NCT03624010 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

35

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension Pulmonary Secondary Heart Failure
Right Sided Heart Failure With Normal Ejection Fraction
Heart Failure With Normal Ejection Fraction

Interventions

DRUG: Levosimendan

Sponsor

Tenax Therapeutics, Inc.

Collaborators

[object Object]